Jeremy Graff's most recent trade in Allarity Therapeutics Inc was a trade of 39,494 Common Stock done . Disclosure was reported to the exchange on Sept. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Allarity Therapeutics Inc | Jeremy R. Graff | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 39,494 | 39,494 | - | - | Common Stock | |
| Allarity Therapeutics Inc | Jeremy R. Graff | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2025 | 39,494 | 223,430 | - | - | Restricted Stock Units | |
| Allarity Therapeutics Inc | Jeremy R. Graff | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. | 30 Sep 2025 | 14,613 | 24,881 | - | 1.6 | 23,089 | Common Stock |
| IN8bio Inc | Jeremy R. Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 63,150 | 63,150 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Jeremy R. Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2025 | 2,049 | 2,049 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Jeremy R. Graff | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Apr 2025 | 2,049 | 0 | - | - | Series B Warrants (right to buy) | |
| Allarity Therapeutics Inc | Jeremy Graff R. | CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 144,441 | 262,924 | - | 0 | Common Stock | |
| IN8bio Inc | Jeremy Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 47,697 | 47,697 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Jeremy Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 33,650 | 33,650 | - | - | Stock Option (right to buy) | |
| IN8bio Inc | Jeremy Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 2,049 | 4,549 | - | - | Common Stock | |
| IN8bio Inc | Graff Jeremy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 2,049 | 2,049 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Graff Jeremy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 2,049 | 2,049 | - | - | Series B Warrants (right to buy) | |
| IN8bio Inc | Jeremy Graff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) |